Evans, S. S., & Clemmons, A. B. (2015). Obinutuzumab: A Novel Anti-CD20 Monoclonal Antibody for Chronic Lymphocytic Leukemia. J Adv Pract Oncol.
Citação norma ChicagoEvans, Sarah S., and Amber B. Clemmons. "Obinutuzumab: A Novel Anti-CD20 Monoclonal Antibody for Chronic Lymphocytic Leukemia." J Adv Pract Oncol 2015.
Citação norma MLAEvans, Sarah S., and Amber B. Clemmons. "Obinutuzumab: A Novel Anti-CD20 Monoclonal Antibody for Chronic Lymphocytic Leukemia." J Adv Pract Oncol 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.